Clinical guidelines play an important role in dermatology because they help dermatologists make safer, more consistent, and more evidence-based decisions. They do not replace clinical judgement, but they provide a structured framework for diagnosing, treating, monitoring, and reviewing different skin conditions. This helps ensure that patients receive care based on the latest research and best available evidence.
In dermatology, guidelines may cover a wide range of conditions and treatments. These can include acne, eczema, psoriasis, skin cancer, urticaria, hair loss, blistering disorders, drug reactions, cosmetic safety, surgical procedures, and systemic therapies. Because skin conditions can vary widely in severity and presentation, having clear guidance helps clinicians choose appropriate treatment pathways and improve patient outcomes.
Dermatology conferences play an important role in introducing and discussing new or updated guidelines. These events allow clinicians to understand recent evidence, ask questions, and discuss how recommendations should be applied in real clinical practice. This helps ensure that guidance is not only published but also properly understood and implemented by healthcare professionals.
When guidelines are introduced and followed effectively, patients benefit from more up-to-date, consistent, and safety-focused care. This can lead to better diagnosis, more appropriate treatment choices, and improved long-term outcomes. Overall, structured guideline updates help ensure that dermatology care continues to evolve in line with the latest medical research and clinical standards.
What Clinical Guidelines Mean in Dermatology
Clinical guidelines are structured recommendations that help healthcare professionals manage specific medical conditions in a safe and consistent way. In dermatology, they may outline how a skin condition should be assessed, what treatment options may be considered, when referral to a specialist is needed, and how patients should be monitored over time. These guidelines are based on the best available evidence and are designed to support good clinical decision-making.
However, guidelines are not strict rules that apply in exactly the same way to every patient. Instead, they provide a careful framework to guide care while still allowing flexibility. A dermatologist must always consider individual factors such as your skin type, medical history, age, symptoms, personal preferences, response to previous treatments, and any relevant risk factors. This ensures that care is tailored to your specific situation rather than applied in a one-size-fits-all way.
This means that guidelines are there to support, not replace, clinical judgement. They help ensure that decisions are evidence-based and consistent, but they still allow room for personalised treatment plans. By combining clinical expertise with guideline recommendations, dermatologists can provide care that is both scientifically informed and individually appropriate for each patient.
Why Dermatology Guidelines Need Regular Updates
Dermatology is a rapidly evolving field because new research, medicines, medical devices, and diagnostic techniques are constantly being developed. As a result, treatments that were once considered standard may later be improved, replaced, or used in a different way based on stronger evidence. This means that clinical knowledge in dermatology is always being refined over time.
Updated guidelines help clinicians keep pace with this growing body of evidence. Changes in recommendations may affect the use of biologic medicines for conditions like psoriasis, newer approaches to skin cancer management, improved treatments for eczema and acne, or updated monitoring requirements for stronger medications. These updates ensure that decisions are based on the most current understanding of safety and effectiveness.
For patients, regularly updated guidelines can make a real difference to the quality of care. They help reduce the use of outdated practices, improve treatment safety, and ensure that patients have access to the most effective options available. Over time, this supports better long-term outcomes, more accurate diagnosis, and more consistent care across different healthcare settings.
How Guidelines Are Developed Before Conferences
New guidelines are usually developed through a structured process before they are discussed at conferences. This process may involve defining the clinical topic, reviewing available evidence, forming expert groups, drafting recommendations, and consulting relevant stakeholders. NICE explains that guideline development includes agreeing review questions, carrying out literature searches, preparing evidence reviews, and using those reviews to develop recommendations. This shows that guidelines are not created casually, but through careful review and professional discussion.
- Defining the Clinical Topic Clearly: Guideline development usually begins by identifying the clinical issue that needs guidance. This helps make sure the recommendations focus on a real healthcare need and address practical questions faced by clinicians and patients.
- Reviewing the Available Evidence: Evidence is gathered through literature searches and research reviews. This step helps guideline developers understand what current studies show, where evidence is strong, and where uncertainty still exists.
- Using Expert Review and Clinical Experience: Expert groups may include clinicians, researchers, and other relevant professionals. Their role is to interpret the evidence carefully and consider how recommendations can work in real clinical settings.
- Drafting and Consulting on Recommendations: Once evidence has been reviewed, draft recommendations are prepared and may be discussed with stakeholders. This helps refine the guidance so it is clear, practical, and suitable for use in healthcare practice.
Guidelines are not simply opinions shared at conferences. They are usually shaped by research, expert review, clinical experience, and the practical needs of healthcare systems. Conferences can provide a useful space to discuss new or developing guidance, but the work often begins long before the event. This structured process helps clinicians make safer, more consistent, and more evidence-based decisions.
The Role of Evidence Review
Evidence review is one of the most important parts of guideline development because recommendations should be based on more than opinion. Researchers and expert panels look at published studies, clinical trials, safety reports, outcome data, and existing clinical practice. This helps them understand what is already known, what remains uncertain, and where guidance is needed. In dermatology, this process is especially important because some conditions are common and well studied, while others are rare and have limited evidence.
- Assessing the Quality of Evidence: Evidence is not only collected but also judged for quality and reliability. Stronger studies, clear outcome data, and consistent findings usually carry more weight when recommendations are developed.
- Checking Relevance to Real Patients: Expert panels also consider whether the evidence applies to everyday clinical practice. A study may be useful, but the panel still needs to think about patient safety, treatment access, side effects, skin type differences, and practical use in clinics.
- Using Expert Consensus When Evidence Is Limited: Not every dermatology condition has a large number of clinical trials or long-term studies. When evidence is limited, recommendations may rely more on expert consensus, clinical experience, and careful risk-benefit judgement.
- Supporting Safer Clinical Decisions: Guidelines help clinicians understand where evidence is strong and where uncertainty remains. This can support safer decision-making, especially when treating rare conditions, complex cases, or patients with individual risk factors.
Evidence review gives guidelines their strength and credibility. It helps separate well-supported recommendations from areas where more research is still needed. In dermatology, where conditions can range from very common to extremely rare, evidence levels may vary widely. Good guidelines help clinicians use the best available knowledge while staying honest about uncertainty and patient safety.
Expert Panels and Consensus Statements
Guideline development in dermatology often involves expert panels made up of a wide range of professionals. These may include dermatologists, researchers, methodologists, surgeons, nurses, pharmacists, and sometimes patient representatives. By bringing together different areas of expertise, these groups can ensure that recommendations are balanced, practical, and based on the best available evidence.
Expert consensus becomes especially important when evidence is still developing or when a condition is rare and large studies are limited. In these situations, clinical experience and collective professional judgement help guide safe and reasonable practice until stronger research becomes available. This allows clinicians to still offer structured advice even when the evidence base is not yet complete.
The European Academy of Dermatology and Venereology explains that clinical guidelines and recommendations are used to define best practice, while consensus statements are often used to provide expert guidance where evidence is still evolving. This distinction is important because it shows that not all dermatology documents carry the same level of evidence or purpose. Some are full clinical guidelines, while others may be recommendations, consensus statements, or position statements, each serving a slightly different role in supporting clinical decision-making.
Professional Consultation Before Publication
Before a clinical guideline is finalised in dermatology, it often goes through a consultation stage. During this process, draft recommendations are reviewed by professional bodies, clinicians, patient organisations, and other relevant stakeholders. This wider input helps ensure that the guidance is not developed in isolation but reflects real-world clinical practice and patient needs.
The consultation process is important because it can highlight practical challenges that may not be obvious during the initial drafting stage. For example, reviewers may identify unclear wording, difficulties in applying recommendations in everyday clinics, issues with treatment access, or concerns related to equality and patient experience. This feedback helps refine the guidance so that it is clearer, more practical, and more patient-centred.
By considering different perspectives before publication, the final guideline becomes more robust and reliable. It also increases trust among healthcare professionals and patients because the recommendations have been reviewed and tested against real clinical situations. This process helps ensure that when guidelines are introduced into practice, they are both evidence-based and workable in everyday dermatology care.
Publication of New Dermatology Guidelines
Once a dermatology guideline has been finalised, it is usually published through a professional body, a medical journal, or an official guideline platform. This allows healthcare professionals to access the full recommendations, supporting evidence, and detailed explanations behind each clinical decision. Publication ensures that the information is widely available and can be used consistently across different healthcare settings.
The British Association of Dermatologists explains that it develops clinical guidelines using a NICE-accredited process and publishes them in the British Journal of Dermatology, where they are freely accessible. This makes it easier for clinicians to review the latest evidence and apply it in their daily practice. Open access publication also helps improve transparency and allows wider professional scrutiny.
However, publication alone is not enough to change clinical practice. Clinicians also need to understand what has changed in the updated guidance and how it applies to real patients in everyday settings. This includes interpreting new recommendations, adapting them to individual cases, and integrating them into existing workflows. Effective use of guidelines depends not only on access to information, but also on understanding and practical application in real clinical care.
Why Conferences Help Introduce Guidelines
Conferences play an important role in helping clinical guidelines move from written documents into practical understanding. While a guideline may contain detailed evidence, tables, and recommendations, it can be complex to interpret in everyday clinical practice. Conference presentations help simplify and highlight the most important changes so that clinicians can quickly understand what has been updated and why.
At these events, guideline authors and dermatology specialists often present the latest recommendations, explain key changes, and answer questions from other healthcare professionals. This creates an opportunity for discussion about real-life challenges, such as how to apply new treatments, manage patient differences, or handle situations where evidence is still evolving. It also helps clinicians understand the reasoning behind new guidance, rather than simply reading the final document.
Conferences are not just academic meetings; they can directly influence everyday medical practice. The information shared can shape what happens later in consultation rooms, outpatient clinics, hospitals, and private dermatology settings. When clinicians return to practice after attending these events, they are often better prepared to apply updated guidelines in a consistent and informed way, which ultimately benefits patient care.
How Guidelines Are Presented at Dermatology Events
New dermatology guidelines are often introduced at professional events using several different formats such as lectures, keynote talks, panel discussions, workshops, clinical case sessions, poster presentations, and update meetings. Each format is designed to communicate information in a slightly different way. This helps ensure that clinicians can understand both the key messages and the more detailed evidence behind the recommendations.
Different formats serve different learning purposes. A lecture usually focuses on explaining the main changes in a guideline and highlighting the most important updates. Workshops allow clinicians to practise applying the recommendations to real-life clinical situations, helping them build confidence in decision-making. Panel discussions give space to explore complex questions, exceptions, and areas where clinical judgement is particularly important.
The Royal Society of Medicine Dermatology Section provides educational events that focus on sharing knowledge and experience in managing complex dermatological cases. These types of professional meetings help clinicians move from simply reading guidelines to understanding how to apply them in everyday practice. This supports better clinical decision-making and ultimately improves patient care.
Explaining What Has Changed
One of the most important parts of a guideline conference session is clearly explaining what has changed compared to previous recommendations. Clinicians need to understand whether there have been updates to treatment pathways, referral criteria, monitoring advice, safety warnings, or patient counselling. This helps ensure that new guidance is applied correctly and consistently in clinical practice.
A guideline update may lead to practical changes in how a condition is managed. For example, it may affect how quickly a patient is escalated for specialist review, which medicines are recommended first-line, when blood tests are required, or when a biopsy should be considered. Even small changes in recommendations can have a significant impact on day-to-day decision-making in clinics and hospitals.
Understanding the reason behind these changes is just as important as knowing what has changed. When clinicians are aware of the evidence and rationale supporting updated guidance, they are more likely to apply it correctly in real patient situations. This improves consistency of care and helps ensure that decisions are based on the most up-to-date and reliable clinical evidence.
Case-Based Learning at Conferences
Dermatology is a highly visual specialty, so case-based learning is widely used at conferences to help clinicians understand how guidelines apply in real practice. Speakers often present real patient examples to show how recommendations can be used in everyday clinical decision-making. This helps bridge the gap between written guidance and practical application.
These cases may include common skin conditions with unusual presentations, rare dermatological diseases, skin of colour cases, treatment failures, medication side effects, or patients with complex medical histories. By reviewing a variety of scenarios, clinicians can see how guideline recommendations may need to be adapted depending on the individual patient. This improves understanding of how flexible and nuanced clinical care can be.
The Royal Society of Medicine highlights that dermatology clinical case meetings allow clinicians to learn about rare conditions, unusual presentations, advances in diagnosis and management, and the impact of skin disease on patients. This approach makes guidelines more practical by showing how they work in real clinical situations and supporting better-informed patient care.
Workshops and Practical Implementation
Workshops at dermatology conferences are designed to help clinicians apply new guidelines in a practical and structured way. While written recommendations explain what should be done, workshops focus on how to do it in real clinical settings. This makes them especially useful when guidelines involve practical skills, clinical pathways, or decision-making processes.
These sessions may cover areas such as dermoscopy techniques, biopsy decisions, severity scoring systems, monitoring of systemic treatments, patient education, consent discussions, and complication management. By working through real examples and supervised exercises, clinicians can practise applying guideline recommendations in a controlled and supportive environment.
A clinical guideline is only truly effective if it can be used confidently in everyday practice. Workshops help bridge the gap between reading recommendations and implementing them safely in clinic. This hands-on approach supports better understanding, reduces uncertainty, and helps ensure that updated guidance is applied consistently and appropriately in-patient care.
Skin Cancer Guidelines at Conferences
Skin cancer guidelines are one of the most important topics discussed at dermatology conferences because early recognition and correct management can significantly affect patient outcomes. Updates in this area may cover how to assess skin lesions, use dermoscopy effectively, decide when a biopsy is needed, determine appropriate excision margins, manage referral urgency, plan follow-up, and provide patient counselling.
At conferences, this guidance is often presented in a very practical way. Speakers may use clinical images, real case examples, and surgical discussions to help clinicians recognise warning signs more accurately. This visual and case-based approach is especially important in dermatology, where subtle differences in skin lesions can change the diagnosis and treatment plan.
The goal of updated skin cancer guidance is to support clinicians in making balanced decisions. This includes identifying suspicious lesions early enough to improve outcomes, while also avoiding unnecessary procedures for clearly benign conditions. By applying structured guidance, clinicians can improve diagnostic accuracy, reduce delays in treatment, and ensure patients receive appropriate and timely care.
Inflammatory Skin Disease Guidelines
Guidelines for inflammatory skin diseases such as eczema, psoriasis, urticaria, hidradenitis suppurativa, and lupus-related skin conditions are a major focus at dermatology conferences because these conditions often require long-term and ongoing management. Updates in this area help clinicians stay informed about the most effective and safest approaches to treatment.
Conference discussions often explore when to use topical treatments, when to escalate to more advanced therapies, when to consider systemic medicines, and how to monitor patients safely during treatment. These decisions are important because inflammatory skin diseases can change over time, and treatment needs may vary depending on severity and response.
It is also important to understand that inflammatory skin disease is not only about visible skin symptoms. Modern guidelines consider factors such as itch, pain, sleep disturbance, quality of life, frequency of flares, infection risk, and treatment burden. This broader approach helps ensure that care focuses not just on the skin itself, but also on the overall impact of the condition on the patient’s daily life.
Guidelines for Systemic Medicines and Biologics
Some dermatology treatments are powerful and need careful monitoring because they affect more than the skin. These may include immunosuppressants, retinoids, biologic medicines, and other systemic treatments that work throughout the body. While these treatments can be very helpful for selected patients, they must be used with clear safety checks. This is why updated guidance is important for both clinicians and patients.
- Blood Tests and Ongoing Monitoring: New guidance may affect how often blood tests are needed before and during treatment. These checks can help monitor liver function, kidney function, blood counts, inflammation markers, or other safety factors depending on the medicine being used.
- Infection Screening and Vaccination Advice: Some systemic medicines and biologics can affect the immune system, so infection screening may be required before treatment starts. Guidance may also include advice about vaccinations, infection risk, and what patients should do if they become unwell during treatment.
- Pregnancy Precautions and Safety Planning: Certain dermatology medicines may not be suitable during pregnancy or when planning pregnancy. Clear guidelines help clinicians explain contraception requirements, pregnancy precautions, and safer alternatives where needed.
- Side-Effect Review and Long-Term Care: Long-term treatment should include regular review of side effects, treatment response, and whether the medicine is still the right option. Structured monitoring helps reduce risks and makes it easier to identify problems early.
Conferences help clinicians understand how to use systemic medicines and biologics safely in real practice. They give doctors a chance to discuss updated guidance, monitoring requirements, risk management, and patient communication. Patients benefit when treatment is not only effective, but also carefully supervised. Clear monitoring and honest explanation of risks can make complex dermatology treatment safer and more reassuring.
Guidelines and Skin of Colour
Modern dermatology guidelines increasingly take skin of colour into account because skin conditions can present differently depending on pigmentation. For example, redness and inflammation may be less obvious in darker skin tones, which can sometimes make diagnosis more challenging. This means clinicians need to be aware of these differences to avoid missed or delayed diagnoses.
At conferences, these issues are often highlighted through diverse clinical images, case discussions, and expert talks that focus on diagnostic gaps. These sessions encourage clinicians to think more carefully about how pigmentation affects disease appearance, as well as factors such as scarring risk, hair type, and cultural skin and hair care practices. This helps improve diagnostic accuracy and treatment decisions across different patient groups.
This is particularly important in cities like London, where patients come from a wide range of ethnic and cultural backgrounds. Guidelines that reflect this diversity help ensure more accurate diagnosis and fairer care for all skin types. By improving awareness and representation in clinical education, dermatology guidance can better support equitable and effective treatment across all populations.
Patient Experience and Shared Decision-Making
Modern dermatology guidelines increasingly place importance on patient experience, not just clinical signs seen on examination. A skin condition may appear mild from a medical point of view, but it can still cause significant discomfort, embarrassment, or emotional distress for the patient. This difference in perspective is an important part of dermatology care.
At conferences, discussions often include quality of life, treatment burden, adherence to medication, communication challenges, and shared decision-making. These topics help clinicians understand how treatments affect patients in real life, including how easy they are to use and how they fit into daily routines. This ensures that care is not only clinically effective but also practical and acceptable for the patient.
Shared decision-making means that you, as a patient, are involved in choosing your treatment alongside your dermatologist. The clinician uses guideline-based medical knowledge, but also considers what matters most to you, such as comfort, lifestyle, and treatment preferences. This approach helps ensure that dermatology care focuses not only on clearing the skin, but also on improving overall well-being and patient satisfaction.
From Conference Discussion to Clinic Practice
After guidelines are discussed at conferences, they still need to be introduced into everyday clinical practice. This process involves more than simply learning the recommendations. Clinics often need to update their internal systems, including treatment protocols, patient information leaflets, consent forms, referral pathways, prescribing processes, and follow-up schedules. These changes help ensure that new guidance can be applied safely and consistently.
Implementation usually takes time because both people and systems need to adapt. Even if a dermatologist understands the updated guideline, the wider clinic team also needs to be familiar with it. Administrative processes, digital systems, and clinical workflows may all need adjustments to support the new recommendations properly. This step is essential to make sure that changes are not only understood but also practically usable in real-world settings.
For patients, these updates can lead to noticeable improvements in care. You may receive more up-to-date treatment advice, clearer safety information, or different monitoring schedules depending on the new guidance. Follow-up appointments may also become more structured, ensuring closer and more consistent review where needed. Overall, the transition from conference discussion to clinic practice helps ensure that patients benefit directly from the latest dermatology evidence in a safe and organised way.
Audits and Measuring Guideline Use
Guidelines in dermatology are often supported by audit and quality improvement processes, which help ensure that recommended care is being followed in real clinical practice. An audit allows clinics to compare everyday patient care with current guideline standards and identify any gaps. This helps maintain safe, consistent, and evidence-based dermatology services.
The British Association of Dermatologists explains that its guidelines and standards work supports clinical excellence through both clinical guidelines and clinical audit. This ensures that recommendations are not only published and discussed, but also reviewed in real-world settings. Audit findings can then be used to improve systems, training, and patient care pathways.
Audits may assess whether patients are receiving correct monitoring for treatments, whether referrals are managed appropriately, and whether treatment pathways are being followed. They can also review safety checks and follow-up care. Overall, audits help ensure that what is agreed in guidelines and conferences is consistently reflected in everyday patient care.
What Patients Should Understand About Guidelines
Patients do not need to read or understand every dermatology guideline in detail, but it can be helpful to know that guidelines exist to support safe, consistent, and up-to-date care. They are used by dermatologists to guide decisions, but they are not something patients are expected to follow directly. Instead, they work in the background to help ensure treatment is based on the latest evidence.
As a patient, you are encouraged to ask questions during your appointment. You can ask why a particular treatment is being recommended, what other options may be available, and what kind of monitoring or follow-up is needed. You can also ask how the treatment plan fits your specific condition and what results you might realistically expect. These discussions help you feel more informed and involved in your care.
It is also important to understand that guidelines do not mean every patient receives the same treatment. Even when guidelines are followed, dermatology care is still personalised. Your dermatologist will consider your individual symptoms, skin type, medical history, and preferences before deciding on the most appropriate approach for you.
FAQs:
1. What are dermatology guidelines?
Dermatology guidelines are structured recommendations that help clinicians assess, diagnose, treat, monitor, and review skin conditions using the best available evidence.
2. Why do dermatology guidelines need regular updates?
Guidelines need regular updates because dermatology is constantly changing. New research, medicines, devices, diagnostic tools, and safety information can change how skin conditions should be managed.
3. How are new dermatology guidelines developed?
New guidelines are usually developed through evidence reviews, expert panel discussions, clinical experience, stakeholder consultation, and careful drafting before they are published or presented.
4. Why are guidelines discussed at dermatology conferences?
Conferences help clinicians understand new or updated guidelines more clearly. They allow experts to explain key changes, answer questions, discuss practical challenges, and show how recommendations apply in real clinical practice.
5. How are new guidelines presented at conferences?
Guidelines may be presented through lectures, panel discussions, workshops, clinical case sessions, keynote talks, poster presentations, and update meetings.
6. How do conferences help clinicians apply guidelines in practice?
Conferences use real case examples, workshops, and expert discussion to show how guidelines should be applied to different patients, including complex cases, unusual presentations, and situations where clinical judgement is needed.
7. Do guidelines replace a dermatologist’s judgement?
No, guidelines support clinical judgement but do not replace it. A dermatologist still needs to consider your skin type, symptoms, medical history, treatment response, preferences, and individual risk factors.
8. What types of dermatology guidelines are commonly discussed?
Guidelines may cover acne, eczema, psoriasis, skin cancer, urticaria, hair loss, blistering disorders, drug reactions, cosmetic safety, surgical procedures, systemic medicines, and biologic treatments.
9. How do patients benefit from updated dermatology guidelines?
Patients benefit through more consistent, evidence-based, up-to-date, and safety-focused care. Updated guidelines can support better diagnosis, safer treatment choices, clearer monitoring, and improved long-term outcomes.
10. Are dermatology guidelines the same for every patient?
No, dermatology guidelines do not mean every patient receives the same treatment. They provide a framework, but your dermatologist should personalise care based on your condition, skin type, medical history, lifestyle, and treatment goals.
Final Thoughts: How Dermatology Guidelines Shape Modern Skin Care
Dermatology guidelines are designed to ensure that patient care is safe, consistent, and based on the strongest available scientific evidence. Although they are often developed and refined through detailed research reviews and professional discussion, their purpose is practical—helping clinicians make informed decisions in everyday clinical settings. Conferences play a key role in this process by allowing experts to explain updates clearly, discuss real-world challenges, and ensure that new recommendations can be applied effectively in practice.
At the same time, it is important to remember that guidelines are not rigid instructions. They provide a structured framework, but dermatologists still tailor treatment to each individual based on their symptoms, medical history, and personal needs. If you are concerned about a skin condition or want expert guidance, you can find more information through the London Dermatology Centre, where experienced specialists offer personalised care. If you’d like to book a consultation with one of our dermatologists in London, you can contact us at the London Dermatology Centre.
References:
- Signer, B., Mokhtari, A., Cazzaniga, S., Brand, F., Caro, G., de Viragh, P.A., Heidemeyer, K., Hosseini, A., Iorizzo, M., Junge, A., Martignoni, Z., Reygagne, P.E., Piraccini, B.M., Starace, M., Reimer-Taschenbrecker, A., Vogel, C., Obrist, D. and Seyed Jafari, S.M. (2026) Publicly available large language models for trichoscopy: a head-to-head comparison with dermatologists, Diagnostics, 16(1), 169. Available at: https://www.mdpi.com/2075-4418/16/1/169
- Karampinis, E., Zoumpourli, C.-M., Lallas, A., Apalla, Z., Paoli, J., Akay, B.N., Navarrete-Dechent, C., Biswanath, B., Enechukwu, N., Chai, P., Liu, J., Toli, O., Kontogianni, C., Sgouros, D., Katoulis, A., Tzermias, C., Pietkiewicz, P. and Errichetti, E. (2026) Perspectives on artificial intelligence in dermatology: an international cross-sectional study, Medicina, 62(4), 759. Available at: https://www.mdpi.com/1648-9144/62/4/759
- Belzer, A. and Parker, E.R. (2023) Climate change, skin health, and dermatologic disease: a guide for the dermatologist, American Journal of Clinical Dermatology, 24(4), pp. 577-593. Available at: https://pubmed.ncbi.nlm.nih.gov/37336870/
- Balak, D.M.W., Deprez, E., Hilhorst, N.T., Hoorens, I., Gutermuth, J., Bos, W.J.W. and Lambert, J. (2024) Value-based healthcare: a primer for the dermatologist, Dermatology, 240(5-6), pp. 814-822. Available at: https://pubmed.ncbi.nlm.nih.gov/38934138/
- Yadav, A., Yadav, P. and Chander, R. (2019) A dermatologist’s visit to the community: an intriguing perspective, Indian Journal of Dermatology, 64(6), pp. 506-509. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC6859744/